180 related articles for article (PubMed ID: 38365844)
21. An analysis of factors related to recurrence of myxofibrosarcoma.
Kikuta K; Kubota D; Yoshida A; Suzuki Y; Morioka H; Toyama Y; Kobayashi E; Nakatani F; Chuuman H; Kawai A
Jpn J Clin Oncol; 2013 Nov; 43(11):1093-104. PubMed ID: 23969617
[TBL] [Abstract][Full Text] [Related]
22. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy.
Zagars GK; Mullen JR; Pollack A
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):983-94. PubMed ID: 8600111
[TBL] [Abstract][Full Text] [Related]
23. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
[TBL] [Abstract][Full Text] [Related]
24. Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins.
Rhee I; Spazzoli B; Stevens J; Hansa A; Spelman T; Pang G; Guiney M; Powell G; Choong P; Di Bella C
ANZ J Surg; 2023 Mar; 93(3):577-584. PubMed ID: 36772961
[TBL] [Abstract][Full Text] [Related]
25. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
[TBL] [Abstract][Full Text] [Related]
26. PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA.
Zumárraga JP; Batista FAR; Baptista AM; Caiero MT; Martino LPR; de Camargo OP
Acta Ortop Bras; 2018; 26(5):320-324. PubMed ID: 30464713
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors in patients with malignant fibrous histiocytoma of the extremities].
Atalar H; Başarir K; Yildiz Y; Sağlik Y
Acta Orthop Traumatol Turc; 2007; 41(4):271-6. PubMed ID: 18180555
[TBL] [Abstract][Full Text] [Related]
28. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
29. Localized Myxofibrosarcoma: A Retrospective Analysis of Primary Therapy and Prognostic Factors in 134 Patients in a Single Institution.
Pogkas A; Reichardt P; Tunn PU; Niethard M; Werner M; Ghani S
Oncologist; 2024 Apr; 29(4):e544-e552. PubMed ID: 38141181
[TBL] [Abstract][Full Text] [Related]
30. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
[TBL] [Abstract][Full Text] [Related]
31. What is an adequate margin for infiltrative soft-tissue sarcomas?
Fujiwara T; Stevenson J; Parry M; Tsuda Y; Tsoi K; Jeys L
Eur J Surg Oncol; 2020 Feb; 46(2):277-281. PubMed ID: 31627932
[TBL] [Abstract][Full Text] [Related]
32. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
33. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
34. What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?
Sawamura C; Matsumoto S; Shimoji T; Tanizawa T; Ae K
Clin Orthop Relat Res; 2012 Mar; 470(3):700-5. PubMed ID: 21826540
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.
Lin CN; Chou SC; Li CF; Tsai KB; Chen WC; Hsiung CY; Yen CF; Huang HY
J Surg Oncol; 2006 Mar; 93(4):294-303. PubMed ID: 16496357
[TBL] [Abstract][Full Text] [Related]
36. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
Mentzel T; Katenkamp D; Fletcher CD
Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
[TBL] [Abstract][Full Text] [Related]
37. Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases.
Arispe Angulo KR; Logan S; Bahrami A; John I; Billings SD; Agrawal S; Bena J; Mesko N; Folpe AL; Fritchie KJ
Hum Pathol; 2023 Dec; 142():90-95. PubMed ID: 37742946
[TBL] [Abstract][Full Text] [Related]
38. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
[TBL] [Abstract][Full Text] [Related]
39. An Analysis of Tumor- and Surgery-Related Factors that Contribute to Inadvertent Positive Margins Following Soft Tissue Sarcoma Resection.
Gundle KR; Gupta S; Kafchinski L; Griffin AM; Kandel RA; Dickson BC; Chung PW; Catton CN; O'Sullivan B; Ferguson PC; Wunder JS
Ann Surg Oncol; 2017 Aug; 24(8):2137-2144. PubMed ID: 28349339
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.
Nishida Y; Tsukushi S; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2010 Nov; 468(11):3041-6. PubMed ID: 20499293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
